4.0 Article

Patterns of alcohol consumption in France and their medical and social consequences as seen through the family circle and friends and general practitioners

Publisher

MASSON EDITEUR
DOI: 10.1016/j.encep.2014.02.008

Keywords

Alcohol drinking; Alcohol-induced disorders; Social problems; Prevalence

Ask authors/readers for more resources

Background. Data on the frequency of high-risk alcohol consumption and its medical and social consequences in the French general population remain fragmented. Therefore, our aim was twofold: (i) to assess the prevalence of different patterns of alcohol consumption using the AUDIT-C scale, according to two different perspectives, i.e., that of family circle members or friends, and that of the general practitioners (GPs), and (ii) to examine the prevalence of medical and social consequences associated with alcohol consumption profiles. Method. Data were drawn from two national surveys conducted in 2013. Investigators were respectively GPs and family circle members or friends. These surveys were respectively representative of GPs (n=1308) and of the general adult population (n = 1018). Results. The 12-month prevalence rates of harmful or at risk alcohol consumption rose respectively to 11.1% in the GPs adult patients and to 11.9% in the general adult population. The majority of participants with at risk alcohol consumption presented with significant social and medical consequences. Thus, more than seven out of ten participants with chronic at risk consumption endorsed significant negative social event potentially associated with alcohol like withdrawal of driving licence, getting divorced or separated, and losing friends. Over 10% of these participants had liver disease and diabetes mellitus, more than 30% increased blood pressure and nearly 50% anxiety disorder or major depression. Following adjustments for sociodemographic characteristics and alcohol treatment, prevalences of numerous social and medical consequences significantly differed between alcohol-dependent participants, chronic at risk consumers and episodic at risk consumers. Conclusions. Our results suggest that more than one adult out of ten in France showed during the past year harmful or at risk alcohol consumption, which appears insufficiently detected and treated. In addition, the majority of at risk alcohol consumers already presents with serious medical and social consequences. Furthermore, we found that AUDIT-C scale can identify different patterns of alcohol consumption, which form a continuum in terms of medical and social consequences. Our study indicates the need for vigorous education efforts for the public, professionals and policy makers about alcohol use disorders, to encourage help-seeking among those who cannot stop drinking despite considerable harm to themselves and others, and ideally to promote early detection and treatment of individuals with at risk alcohol consumption before the development of social and medical consequences and alcohol dependence. (C) L'Encephale, Paris, 2014.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Toward a generalized developmental model of psychopathological liabilities and psychiatric disorders

Carlos Blanco, Melanie M. Wall, Nicolas Hoertel, Robert F. Krueger, Mark Olfson

Summary: Most risk factors for psychiatric disorders are mediated through broad psychopathological dimensions, supporting the need for a trans-diagnostic approach to etiological research and intervention.

PSYCHOLOGICAL MEDICINE (2023)

Article Gerontology

Telemedicine Readiness Across Medical Conditions in a US National Representative Sample of Older Adults

Jorge M. Rodriguez-Fernandez, Emily Danies, Nicolas Hoertel, William Galanter, Hugo Saner, Oscar H. Franco

Summary: The study revealed that various medical conditions among older adults have a significant impact on their willingness to adopt telemedicine, with chronic illnesses and mood symptoms being barriers while conditions like cancer, hypertension, and arthritis are associated with readiness for telemedicine.

JOURNAL OF APPLIED GERONTOLOGY (2022)

Article Psychiatry

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study

Nicolas Hoertel, Marina Sanchez-Rico, Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Miriam Abellan, Pedro de la Muela, Raphael Vernet, Nathanael Beeker, Antoine Neuraz, Aude Delcuze, Jesus M. Alvarado, Celine Cougoule, Pierre Meneton, Frederic Limosin

Summary: The study found that the use of FIASMA psychotropic medications may reduce the risk of intubation or death in COVID-19 patients. Especially, patients taking FIASMA antidepressants have a lower risk compared to those taking non-FIASMA antidepressants. These findings are important for further evaluating the effectiveness of FIASMA medications against COVID-19.

TRANSLATIONAL PSYCHIATRY (2022)

Article Clinical Neurology

Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study

Margaux Chene, Marina Sanchez-Rico, Carlos Blanco, Rachel Pascal De Raykeer, Cecile Hanon, Pierre Vandel, Frederic Limosin, Nicolas Hoertel

Summary: In older adults with major psychiatric disorders, all psychiatric symptoms are associated with increased mortality, mainly through a general psychopathology dimension. No BPRS item or lower order factor has a significant effect on mortality beyond the general psychopathology factor. Greater number of medical conditions, older age, male sex, and being hospitalized or institutionalized at baseline are significantly associated with this increased risk, independently from the general psychopathology factor.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Article Psychiatry

Early liaison psychiatry consultations and general hospital readmission: A retrospective cohort study

Victoria Lanvin, Helene Vulser, Victoire Vinant, Gilles Chatellier, Guillaume Airagnes, Nicolas Hoertel, Frederic Limosin, Cedric Lemogne

Summary: This study found that earlier psychiatric consultation is associated with fewer 30-day and 7-day readmissions. This suggests that proactive consultation-liaison psychiatric teams could help improve the quality of care and achieve significant economic savings in general hospitals.

GENERAL HOSPITAL PSYCHIATRY (2022)

Article Oncology

Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database

Jacques Medioni, Daniel Scimeca, Yecenia Lopez Marquez, Emmanuelle Leray, Marie Dalichampt, Nicolas Hoertel, Mohammed Bennani, Pascal Trempat, Naoual Boujedaini

Summary: This study evaluated the benefits of homeopathy on the quality of life of patients with nonmetastatic breast cancer. The use of homeopathy in patients with breast cancer after diagnosis has increased, leading to a decrease in medications for palliating cancer treatment side effects. This indicates an improvement in quality of life for patients who use homeopathy.

CLINICAL BREAST CANCER (2023)

Article Psychiatry

Using filled prescription sequences to rank antidepressants: A nationwide replication study

Charles Ouazana-Vedrines, Thomas Lesuffleur, Pierre Denis, Nicolas Hoertel, Frederic Limosin, Antoine Rachas, Philippe Tuppin, Cedric Lemogne

Summary: Ranking antidepressants based on efficacy and tolerability in the general population helps in selecting the best first-line medication. This study aimed to replicate a proof-of-concept study by ranking antidepressants based on prescription sequences consistent with continuation or change. Using a nationwide cohort from the French national health data system, the study provides evidence that prescription sequences are a reliable and reproducible tool for ranking antidepressant treatments in real life settings. The results showed that escitalopram was the most acceptable option, followed by venlafaxine, citalopram, sertraline, fluoxetine, and paroxetine.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Geriatrics & Gerontology

Impact of lithium on mortality among older adults with major psychiatric disorders: A 5-year prospective multicenter study

Emmanuel Leleu, Marina Sanchez-Rico, Miriam Abellan, Carlos Blanco, Sunthavy Yeim, Esther Chaugne, Frederic Limosin, Nicolas Hoertel

Summary: This study examines the association between lithium use and all-cause mortality and specific causes of death among older adults with psychiatric disorders. The results show that lithium use is not significantly associated with all-cause or disease-related mortality, and may be associated with a reduced risk of suicide.

AGING & MENTAL HEALTH (2023)

Article Psychiatry

Trust in sources of information on COVID-19 at the beginning of the pandemic?s first wave and incident persistent symptoms in the population-based CONSTANCES cohort: A prospective study*

Joane Matta, Emmanuel Wiernik, Olivier Robineau, Gianluca Severi, Mathilde Touvier, Clement Gouraud, Charles Ouazana-Vedrines, Victor Pitron, Brigitte Ranque, Nicolas Hoertel, Omer Van den Bergh, Michael Witthoeft, Sofiane Kab, Marcel Goldberg, Marie Zins, Cedric Lemogne

Summary: This study aimed to investigate the association between trust in different sources of information on COVID-19 at the beginning of the pandemic and the burden of incident persistent symptoms. Using data from the French CONSTANCES population-based cohort, the study found that participants with higher trust in government/journalists had fewer incident persistent symptoms at follow-up. Trust in government/journalists and medical doctors/scientists was also associated with a lower likelihood of having at least one symptom.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2023)

Article Biochemistry & Molecular Biology

Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study

Bruce J. Kirenga, Levicatus Mugenyi, Marina Sanchez-Rico, Henry Kyobe, Winters Muttamba, Raymond Mugume, Eliya Mwesigwa, Ezra Kalimo, Vicky Nyombi, Ivan Segawa, Loryndah Olive Namakula, Rogers Sekibira, Wilberforce Kabweru, Rosemary Byanyima, Hellen Aanyu, Pauline Byakika-Kibwika, Henry G. Mwebesa, Nicolas Hoertel, William Bazeyo

Summary: Prior research suggests that fluvoxamine, an SSRI used for mental disorders, may be effective against COVID-19. This study found that fluvoxamine was associated with reduced mortality and increased symptom resolution in inpatients with COVID-19. However, further research is needed to confirm these findings and assess potential side effects.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder

Axel Baptista, Valerian Chambon, Nicolas Hoertel, Mark Olfson, Carlos Blanco, David Cohen, Pierre O. Jacquet

Summary: This study found that the emergence of borderline personality disorder (BPD) is associated with prioritizing short-term reproductive goals over long-term somatic maintenance goals, which can be seen as a developmental response to adverse early life experiences. Early life adversity is directly or indirectly associated with a diagnosis of BPD, and prioritizing short-term reproductive goals further increases the risk of BPD. These findings help explain the physiological and behavioral correlates of BPD.

JAMA PSYCHIATRY (2023)

Article Chemistry, Medicinal

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study

Nicolas Hoertel, Katayoun Rezaei, Marina Sanchez-Rico, Alfonso Delgado-Alvarez, Johannes Kornhuber, Erich Gulbins, Mark Olfson, Charles Ouazana-Vedrines, Alexander Carpinteiro, Celine Cougoule, Katrin Anne Becker, Jesus M. Alvarado, Frederic Limosin

Summary: The study suggests that the use of medications inhibiting acid sphingomyelinase (FIASMA) can reduce the risk of mortality in patients with SARS-CoV-2 infection. The multicenter retrospective observational study included 72,105 adult patients and found a significant association between FIASMA medication use and reduced 28-day mortality risk.

PHARMACEUTICALS (2023)

Article Psychiatry

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19

Marina Sanchez-Rico, Katayoun Rezaei, Alfonso Delgado-Alvarez, Frederic Limosin, Nicolas Hoertel, Jesus M. Alvarado

Summary: Psychiatric and non-psychiatric comorbidity may be associated with increased 28-day mortality among patients with psychiatric disorders and COVID-19, with the exception of a lower risk of death observed in patients with mood disorders.

BRAZILIAN JOURNAL OF PSYCHIATRY (2023)

Article Psychology, Clinical

Acceptalility of Second-Line Antidepressant Medications Using Filled Prescription Sequences in a Nationwide Cohort Study

Charles Ouazana-Vedrines, Thomas Lesuffleur, Pierre Denis, Nicolas Hoertel, Romain Olekhnovitch, Mark Olfson, Carlos Blanco, Frederic Limosin, Antoine Rachas, Philippe Tuppin, Cedric Lemogne

Summary: This nationwide population-based study aimed to rank antidepressants based on their acceptability after first-line treatment failure, providing insights for clinicians on the best second-line options based on the initial treatment.

JOURNAL OF CLINICAL PSYCHIATRY (2022)

Meeting Abstract Psychiatry

Psychiatry training goes virtual: the experience of the first online edition of the EPA Research Summer School

R. De Filippis, D. Almeida, U. Cikrikcili, L. Di Lodovico, M. Filip, L. Fusar-Poli, A. Gurcan, D. Gurrea Salas, K. Mieze, G. Mijaljica, C. Noel, P. Nwaubani, M. Pantic, B. I. Perez Longas, A. Pushko, A. A. Roman-Jarrin, M. Santos, K. Silagadze, M. Sorokin, C. Tapoi, C. Hanon, N. Hoertel, A. Raballo, N. Sartorius, M. Pinto Da Costa

EUROPEAN PSYCHIATRY (2022)

No Data Available